Monthly Archives: May 2016

A Director at Charles Schwab (NYSE: SCHW) is Buying Shares

Yesterday, a Director at Charles Schwab (NYSE: SCHW), John K. Adams, bought shares of SCHW for $149.9k. John K. Adams increased his holding by 31.9% to a total of $327481.22. In addition to John K. Adams, 18 other SCHW executives

A Director at Trupanion (NYSE: TRUP) is Selling Shares

Today, a Director at Trupanion (NYSE: TRUP), Glenn Novotny, sold shares of TRUP for $59.58k. Following Glenn Novotny’s last TRUP Sell transaction on November 24, 2014, the stock climbed by 8.9%. In addition to Glenn Novotny, 10 other TRUP executives

A Director at US Concrete (NASDAQ: USCR) is Selling Shares

Today, a Director at US Concrete (NASDAQ: USCR), Theodore Rossi, sold shares of USCR for $255.9k. This is Rossi’s first Sell trade following 14 Buy transactions. In addition to Theodore Rossi, 14 other USCR executives reported Sell trades in the

The EVP of RPX Corp (NASDAQ: RPXC) is Selling Shares

Today, the EVP of RPX Corp (NASDAQ: RPXC), Mallun Yen, sold shares of RPXC for $73.63k. In addition to Mallun Yen, 8 other RPXC executives reported Sell trades in the last month. This is Yen’s first Sell trade following 4

A Major Shareholder at Actinium Pharmaceuticals (NYSE MKT: ATNM) is Selling Shares

Today, a Major Shareholder at Actinium Pharmaceuticals (NYSE MKT: ATNM), Memorial Sloan-Kettering Cancer Center, sold shares of ATNM for $77.06k. The company has a one year high of $3.74 and a one year low of $1.52. Currently, Actinium Pharmaceuticals has

A Director at SurModics (NASDAQ: SRDX) is Selling Shares

Today, a Director at SurModics (NASDAQ: SRDX), Susan Knight, sold shares of SRDX for $22.73k. Following Susan Knight’s last SRDX Sell transaction on May 18, 2016, the stock climbed by 0.6%. In addition to Susan Knight, one other SRDX executive